Canntab Therapeutics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022
April 29, 2022 at 04:55 pm EDT
Canntab Therapeutics Limited reported earnings results for the third quarter and nine months ended February 28, 2022. For the third quarter, the company reported net loss was CAD 0.418338 million compared to CAD 0.604697 million a year ago. Basic loss per share from continuing operations was CAD 0.011 compared to CAD 0.017 a year ago.
For the nine months, net loss was CAD 2.24 million compared to CAD 2.12 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.062 a year ago.